|
Food safety and quality
|
|
|
| |
在线帮助 词汇
本数据库保存了关于JECFA推荐的兽药最高残留量的最近信息。粮农组织第41号食品和营养文件公布的所有专题文章电子版均可提供。这些专题文章仅有英文, 虽然数据库某些部分、询问页和背景资料有英文、法文、西班牙文、阿拉伯文和中文。
| 兽药 |
Neomycin |
| 功能分类 |
Antimicrobial agent |
| 最新评价 |
2003 |
| 食品添加剂和污染物联合专家委员会 |
60 |
| 每日允许摄入量 |
0-60 µg/kg bw |
| 每日允许摄入量状况 |
Full |
| 残留量专题文集 |
|
| 残留标示物 |
Parent drug |
| 建议的最高残留限量 |
| Cattle | Fat | 500 µg/kg | F | | Cattle | Kidney | 10000 µg/kg | F | | Cattle | Liver | 500 µg/kg | F | | Cattle | Milk | 1500 µg/kg | F | | Cattle | Muscle | 500 µg/kg | F | | Chicken | Eggs | 500 µg/kg | F | | Chicken | Fat | 500 µg/kg | F | | Chicken | Kidney | 10000 µg/kg | F | | Chicken | Liver | 500 µg/kg | F | | Chicken | Muscle | 500 µg/kg | F | | Duck | Fat | 500 µg/kg | F | | Duck | Kidney | 10000 µg/kg | F | | Duck | Liver | 500 µg/kg | F | | Duck | Muscle | 500 µg/kg | F | | Goat | Fat | 500 µg/kg | F | | Goat | Kidney | 10000 µg/kg | F | | Goat | Liver | 500 µg/kg | F | | Goat | Muscle | 500 µg/kg | F | | Pig | Fat | 500 µg/kg | F | | Pig | Kidney | 10000 µg/kg | F | | Pig | Liver | 500 µg/kg | F | | Pig | Muscle | 500 µg/kg | F | | Sheep | Fat | 500 µg/kg | F | | Sheep | Kidney | 10000 µg/kg | F | | Sheep | Liver | 500 µg/kg | F | | Sheep | Muscle | 500 µg/kg | F | | Turkey | Fat | 500 µg/kg | F | | Turkey | Kidney | 10000 µg/kg | F | | Turkey | Liver | 500 µg/kg | F | | Turkey | Muscle | 500 µg/kg | F |
|
| 其他说明 |
|
| 评价概要 |
Committee considered the following factors in recommending MRLs: - An ADI of 0 - 60 mg/kg bodyweight based on a toxicological end-point, which results in a maximum daily intake of 3600 mg for a 60 kg person. - Neomycin undergoes negligible metabolism following parenteral administration in animals and the parent drug represents the total of the residues present in the tissues. - Neomycin is the marker residue for tissues, milk and eggs. - A validated HPLC method with a LOQ of 0.1 mg/mL for neomycin in cow's milk is available and is suitable for routine use. - Concentrations of neomycin up to 2 mg/l had no effect on bacterial starter cultures used in the production of fermented milk products. - Data on residues in milk supported an MRL for cow's milk of 1500 mg/kg. - Information on the registered use patterns for injectable formulations of neomycin in food-producing animals was requested from Governments and considered. The information indicated that use of parenteral formulations is not regarded as good practice in the use of veterinary drugs, and few such products were found to be approved. - The MRLs for kidney of 20000 mg/kg and for liver of 15000 mg/kg recommended by the Committee at its 52nd Meeting to accommodate use of parenteral formulations are therefore unnecessary. The Committee, having considered the data submitted since its 43rd meeting, decided to revert to the MRLs for cattle kidney and liver that it had recommended at its 47th meeting. Based on the consumption of 300 g of muscle, 100 g of liver, 50 g of kidney, 50 g of fat, 1.5 kg of milk and 100 g of eggs, the theoretical maximum daily intake of neomycin residues is 3025 mg. This accounts for 84 % of the ADI of 3600 mg for a person of 60 kg bodyweight. FNP 41/15 |
|
|
|